Total Payments
$1,697
2022 Payments
$20.46
Companies
7
Transactions
40
Medicare Patients
2,047
Medicare Billing
$111,420
Payment Breakdown by Category
Food & Beverage$1,427 (84.1%)
Education$270.06 (15.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,427 | 31 | 84.1% |
| Education | $270.06 | 9 | 15.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,286 | 28 | $0 (2019) |
| Orexigen Therapeutics, Inc. | $104.58 | 1 | $0 (2017) |
| Corcept Therapeutics | $103.72 | 1 | $0 (2018) |
| Lilly USA, LLC | $100.54 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $68.62 | 1 | $0 (2017) |
| Endo Pharmaceuticals Inc. | $21.96 | 1 | $0 (2019) |
| Eisai Inc. | $11.90 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $20.46 | 1 | Lilly USA, LLC ($20.46) |
| 2019 | $464.24 | 11 | Novo Nordisk Inc ($442.28) |
| 2018 | $336.39 | 10 | Novo Nordisk Inc ($167.52) |
| 2017 | $875.76 | 18 | Novo Nordisk Inc ($675.73) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/29/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Diabetes | ||||||
| 10/24/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $106.61 | General |
| Category: Obesity | ||||||
| 10/10/2019 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/10/2019 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/10/2019 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/10/2019 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/10/2019 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/10/2019 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/10/2019 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/10/2019 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 01/18/2019 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 01/17/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $77.51 | General |
| Category: Diabetes | ||||||
| 11/16/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Diabetes | ||||||
| 10/19/2018 | Eisai Inc. | Belviq (Drug) | Education | Cash or cash equivalent | $11.90 | General |
| Category: Nutrition and Weight Loss | ||||||
| 09/06/2018 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $103.72 | General |
| Category: Endocrinology | ||||||
| 08/24/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.11 | General |
| 07/13/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 06/15/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
| 06/06/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Obesity | ||||||
| 04/20/2018 | Lilly USA, LLC | TRADJENTA (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Diabetes | ||||||
| 03/06/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Obesity | ||||||
| 01/19/2018 | Lilly USA, LLC | TRADJENTA (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Diabetes | ||||||
| 12/20/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $77.85 | General |
| Category: Obesity | ||||||
| 12/16/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $35.71 | General |
| Category: Obesity | ||||||
| 12/15/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 13 | 519 | 581 | $68,941 | $24,202 |
| 2021 | 27 | 1,160 | 1,362 | $172,909 | $65,811 |
| 2020 | 15 | 368 | 428 | $62,357 | $21,408 |
Total Patients
2,047
Total Services
2,371
Medicare Billing
$111,420
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 125 | $28,641 | $10,065 | 35.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 38 | 38 | $8,702 | $5,242 | 60.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 76 | $11,932 | $4,601 | 38.6% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2022 | 12 | 13 | $3,900 | $969.00 | 24.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 44 | 44 | $3,036 | $586.43 | 19.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 52 | 52 | $2,860 | $546.37 | 19.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2022 | 24 | 24 | $1,248 | $460.97 | 36.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 51 | 52 | $2,080 | $399.22 | 19.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 18 | 20 | $1,720 | $333.79 | 19.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 31 | 34 | $1,709 | $328.35 | 19.2% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2022 | 12 | 13 | $975.00 | $323.00 | 33.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 68 | 77 | $1,540 | $229.80 | 14.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 11 | 13 | $598.00 | $116.63 | 19.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 160 | 237 | $54,304 | $22,817 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 78 | 78 | $18,016 | $10,934 | 60.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 119 | 139 | $21,823 | $9,468 | 43.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $11,479 | $3,514 | 30.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 43 | 43 | $4,558 | $2,806 | 61.6% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2021 | 33 | 35 | $10,500 | $2,625 | 25.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 18 | 18 | $5,895 | $2,249 | 38.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 30 | 31 | $3,349 | $1,528 | 45.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $4,465 | $1,375 | 30.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 67 | 71 | $4,899 | $950.69 | 19.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 80 | 90 | $4,950 | $950.40 | 19.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 50 | 50 | $2,753 | $899.00 | 32.7% |
About Dr. Gregory Wallin, MD
Dr. Gregory Wallin, MD is a Obesity Medicine healthcare provider based in Benton Harbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1790070803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Wallin, MD has received a total of $1,697 in payments from pharmaceutical and medical device companies, with $20.46 received in 2022. These payments were reported across 40 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,427).
As a Medicare-enrolled provider, Wallin has provided services to 2,047 Medicare beneficiaries, totaling 2,371 services with total Medicare billing of $111,420. Data is available for 3 years (2020–2022), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Obesity Medicine
- Other Specialties Family Medicine
- Location Benton Harbor, MI
- Active Since 06/16/2011
- Last Updated 01/26/2024
- Taxonomy Code 207QB0002X
- Entity Type Individual
- NPI Number 1790070803
Products in Payments
- Saxenda (Drug) $807.95
- CONTRAVE (Drug) $104.58
- Korlym (Drug) $103.72
- Ozempic (Drug) $77.51
- JARDIANCE (Drug) $68.62
- TRULICITY (Drug) $47.13
- TRADJENTA (Drug) $41.19
- Victoza (Drug) $36.90
- NASCOBAL (Drug) $21.96
- HUMALOG (Drug) $12.22
- Belviq (Drug) $11.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.